Grippferon with loratadine, nasal ointment 10000 me+2 mg/g 5 g

The drug Grippferon with loratadine is based on recombinant human interferon alpha-2b and a second generation antihistamine substance – loratadine.

It is well known that patients with allergic diseases, particularly allergic rhinitis, have an increased susceptibility to respiratory viral infections.

Inflammatory changes in the respiratory mucosa of patients with allergic rhinitis contribute to the decrease of antiviral and antimicrobial protection and suppression of local immunity. This creates a favorable environment for reproduction of respiratory viruses.

The connection between respiratory infection and exacerbation of allergies has been proved by numerous clinical observations and laboratory studies.

Indications

The product is intended for the prevention and treatment of flu and acute respiratory infections as part of the treatment of adults, including patients with allergic rhinitis.

Active ingredient

Interferon alfa-2b, Loratadine

Composition

Nasal ointment

1 g of ointment contains:

active ingredients:

interferon alfa-2b human recombinant not less than 10000 IU,

loratadine 2 mg,

excipients:

boric acid 1 mg,

sodium tetraborate decahydrate 1 mg,

glycerol 90 mg,

dinatrium edetate dihydrate 1 mg,

hypromellose 2.5 mg,

macrogol 4000 – 200 mg,

macrogol 400 – 600 mg,

purified water to 1 g.

.